Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
21 studies found for:    Open Studies | "Tetanus"
Show Display Options
Rank Status Study
1 Recruiting Post Marketing Surveillance for ADACEL™ in South Korea
Conditions: Diphtheria;   Tetanus;   Pertussis
Intervention: Biological: ADACEL™:Adsorbed Diphtheria, Tetanus Toxoids and Component Pertussis Combined
2 Recruiting Regulatory Post-Marketing Surveillance Study for TETRAXIM™
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis
Intervention: Biological: TETRAXIM™: Combined adsorbed diphtheria, tetanus, acellular pertussis and enhanced inactivated polio
3 Recruiting Post-marketing Surveillance to Assess the Safety of Infanrix-IPV Vaccine Among Infants and Children in Korea
Conditions: Acellular Pertussis;   Diphtheria;   Tetanus;   Poliomyelitis
Intervention: Other: Infanrix-IPV data collection
4 Not yet recruiting Post-authorization Safety Study of Euforvac-Hib Vaccine for Active Primary Immunization in Infants From 6 Weeks
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Haemophilus Influenza Type B
Intervention:
5 Recruiting Post-marketing Surveillance to Assess the Safety of Boostrix Vaccine Given According to Prescribing Information in Korea
Conditions: Tetanus;   Acellular Pertussis;   Diphtheria
Interventions: Biological: Boostrix;   Other: Safety data collection
6 Recruiting DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Infants
Conditions: Diphtheria;   Tetanus;   Pertussis;   Haemophilus Influenzae Type b Infection;   Poliomyelitis;   Hepatitis B
Interventions: Biological: DTaP-IPV-Hep B-PRP~T combined vaccine;   Biological: DTaP-IPV//PRP~T and Hepatitis B vaccine
7 Recruiting Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease
Conditions: Haemophilus Infections;   Diphtheria;   Tetanus;   Polio;   Pertussis
Intervention: Biological: DTaP-IPV/Hib
8 Unknown  Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Haemophilus Influenzae Type B
Intervention: Biological: Shan 5
9 Recruiting DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants
Conditions: Tetanus;   Diphtheria;   Pertussis;   Poliomyelitis;   Bacterial Meningitis
Interventions: Biological: DTaP-IPV/Hib Combined vaccine;   Biological: DTaP-IPV vaccine and Hib vaccine
10 Unknown  Vaccination Against Pertussis, Tetanus and Diphtheria in Patients Suffering From Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Biological: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed)
11 Not yet recruiting Hepatitis B Vaccination in Infants
Conditions: Meningococcal Disease;   Pneumococcal Disease;   Haemophilus Influenzae Serotype b Disease;   Diphtheria, Tetanus and Pertussis;   Hepatitis b
Interventions: Biological: Menjugate;   Biological: Menitorix;   Biological: NeisVac-C
12 Not yet recruiting Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Pregnant Women.
Condition: Diphtheria-Tetanus-acellular Pertussis Vaccines
Interventions: Biological: Boostrix™;   Drug: Saline placebo
13 Recruiting Diphtheria, Tetanus, Poliomyelitis -Pertussis-Hib Immunisation in Preterm-born Neonates
Conditions: Hib Immunisation in Very Preterm-born Infants;   Pertussis Immunisation in Very Preterm-born Infants
Interventions: Biological: Three vaccine injections DTP-pertussis-Hib;   Biological: Two vaccine injections DTP-pertussis-Hib
14 Recruiting TDAP Safety in Pregnant Women
Condition: Pertussis
Intervention:
15 Unknown  Immunotherapy for Colorectal Cancers Using CEA-Pulsed Dendritic Cells and Subsequent IL-2 Treatment
Condition: Colorectal Cancer
Intervention: Biological: CEA pulsed dendritic cells
16 Not yet recruiting DC Migration Study for Newly-Diagnosed GBM
Conditions: Glioblastoma;   Astrocytoma, Grade IV;   Giant Cell Glioblastoma;   Glioblastoma Multiforme
Interventions: Biological: Group I autologous unpulsed DCs;   Biological: Group II tetanus diptheria toxoid;   Biological: Human CMV pp65-LAMP mRNA-pulsed autologous DCs;   Biological: 111In-labeled DCs;   Drug: Temozolomide
17 Unknown  Safety and Immunogenicity of Apical Membrane Antigen 1 (PfAMA-1-FVO[25-545])
Condition: Malaria
Interventions: Biological: Malaria vaccine AMA1 (PfAMA-1-FVO[25-545];   Biological: AMA1
18 Recruiting Immunogenicity and Safety of Vaccinations in Immunocompromised Persons
Conditions: Arthritis, Rheumatoid;   Spondylarthritis;   Vasculitis
Intervention: Biological: Hepatitis A vaccine and tetanus vaccine
19 Recruiting A Protocol to Collect Human Serum Samples From Healthy Adults for Use as Quality Controls Samples in GlaxoSmithKline (GSK) Biologicals' Assays
Condition: Meningococcal
Interventions: Biological: Menveo®;   Biological: Boostrix®;   Biological: Pneumovax 23®;   Biological: Prevnar 13®
20 Recruiting A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)
Condition: Systemic Lupus Erythematosus
Interventions: Biological: Belimumab plus Early Vaccination;   Biological: Belimumab plus Late Vaccination

   Previous Page Studies Shown (1-20) Next Page (21-21) Show next page of results    Last Page
Indicates status has not been verified in more than two years